301096.SZ
百诚医药
SZSE · M 科研服务 · CN
CNY 48.20
−3.15%Margins
Gross margin
41.6%
EBITDA margin
9.7%
EBIT margin
-6.9%
Net margin
-7.2%
FCF margin
-26.8%
-2.1%
Return on equity
-1.4%
Return on assets
-1.5%
Return on invested capital
0.19x
Asset turnover
-CNY 91.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026